Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell - 9-MTH group results

Feb 13 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to  
                Dec 31, 2019        Dec 31, 2018      Mar 31, 2020 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales            891 mln             806 mln            1.43     
                 (+10.6 pct)         (+17.3 pct)      (+31.8 pct)  
  Operating     loss 671 mln        loss 587 mln      loss 756 mln 
  Recurring     loss 656 mln        loss 456 mln      loss 687 mln 
  Net           loss 663 mln        loss 430 mln      loss 687 mln 
  EPS           loss 9.32 yen       loss 6.37 yen    loss 9.66 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news